Cargando...
Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus
Lipid-lowering therapy is used very commonly nowadays not only for the optimization of the lipid profile but also to reduce cardiovascular risk. However, some studies have linked the use of certain lipid-lowering agents with an increased risk for impaired glycemic control and new-onset diabetes mell...
Guardado en:
| Publicado en: | Drugs Context |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioExcel Publishing Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6267678/ https://ncbi.nlm.nih.gov/pubmed/30515229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212562 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|